| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.21 | 4e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.092 | 0.04 |